This session will explore the intricate molecular pathways that link immune responses to metabolic processes. Emphasis will be placed on the role of metabolic enzymes and signaling molecules in regulating immune cell function.

This track focuses on the interplay between inflammatory signaling pathways and the development of metabolic disorders. Researchers will present findings on how chronic inflammation contributes to conditions such as obesity and diabetes.

This session will delve into the complex networks of cytokines that govern immune regulation and their impact on metabolic health. Discussions will include the therapeutic potential of targeting cytokine signaling in metabolic diseases.

This track aims to bridge the gap between basic immunometabolic research and clinical applications. Presentations will highlight innovative strategies for translating laboratory findings into effective therapies for metabolic diseases.

This session will investigate the mechanisms underlying metabolic inflammation and its implications for immune function. Researchers will discuss how metabolic stress influences inflammatory responses in various tissues.

This track will examine the role of immune cell signaling in maintaining metabolic homeostasis. Topics will include the influence of immune cells on energy metabolism and their potential as therapeutic targets.

This session will focus on the identification and validation of novel biomarkers associated with immunometabolic diseases. Researchers will present data on how these biomarkers can enhance diagnosis and treatment strategies.

This track will explore the impact of dietary interventions on immune metabolism and inflammatory signaling. Discussions will include the role of specific nutrients and dietary patterns in modulating immune responses.

This session will investigate the relationship between the microbiome and immunometabolic pathways. Presentations will highlight how microbial metabolites can influence immune cell function and metabolic health.

This track will address the role of immunometabolism in cancer progression and therapy resistance. Researchers will discuss how metabolic reprogramming of immune cells can affect tumor microenvironments.

This session will highlight emerging therapeutic strategies targeting immunometabolic disorders. Presentations will cover novel pharmacological agents and their mechanisms of action in modulating immune and metabolic pathways.